For A Shared Future, Bioperfectus Story with Sierra Leone

Company news
2022-02-16

 

Bioperfectus Nucleic Acid Extraction System SSNP-3000A arrived at Sierra Leone-China Friendship Biological Safety Laboratory (SLE-CHN Biosafety Lab) during the Chinese New Year Festival.

 

 

About the history of The Sierra Leone-China Friendship Biological Safety Laboratory

 

The Sierra Leone-China Friendship Biological Safety Laboratory, a fixed Biosafety Level 3(P3) laboratory in Sierra Leone, was established by the Chinese government and has been active in EBOV detection since 11 March 2015. The Ebola virus disease (EVD) outbreak that occurred in West Africa between 2014 and 2015 was the largest EDV epidemic since the identification of the Ebola virus (EBOV) in 1976. Shortly after EDV emerged in West Africa in 2014, the Chinese government offered to provide large-scale medical aid to the three most strongly affected countries. The aid included establishing a fixed Biosafety Level 3 (BSL-3) laboratory in Freetown, the capital city of Sierra Leone.

 

Bioperfectus Molecular Diagnostics Solution for Ebola & COVID-19.

 

As one of the leading molecular diagnostic suppliers for infectious diseases, Bioperfectus has been serving the health and wellness of human life for more than a decade since 2010. As early as the Ebola outbreak in West Africa in 2014, Bioperfectus developed Ebola Virus Real-Time PCR Kit. The kit was sent to West Africa as medical aid from China.

Since the outbreak of the COVID-19 pandemic, Bioperfectus has been assisting Africa in providing PCR lab equipment and reagents to local molecular diagnostics laboratories. On September 9th, 2021, Bioperfectus molecular diagnostic products were sent as medical aid products to Ethiopia, where African Union is located.

 

 

 

The whole instruction process lasted for 1 hour, which turned out to be smooth and successful. Bioperfectus Nucleic Acid Extraction System SSNP-3000A can extract a maximum of 64 samples per run. For a day (24 hours), it can extract over 6300 samples (excluding decontamination operation). With the automation nucleic acid extraction system, the workload and efficiency of the lab will be significantly improved.

 

 

Bioperfectus for Africa: For a shared future

 

Bioperfectus is dedicated to improving African molecular diagnostics development by establishing long-term cooperation with the local molecular diagnostic laboratory. With a 24/7 online e-Support platform and fast-reaction customer service, the local laboratory is fully assured in installing and operating the PCR laboratory molecular diagnostic machines.

 

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14